Itga5-flox Mouse
Common Name
Itga5-flox
제품 ID
S-CKO-03153
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-16402-Itga5-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Itga5-flox Mouse (카탈로그 번호 S-CKO-03153)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Itga5-flox
품종 계통계통 ID
CKOCMP-16402-Itga5-B6J-VA
유전자명
제품 ID
S-CKO-03153
유전자 별칭
Fnra, VLA5, Cd49e
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 15
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000023128
NCBI 전사체 ID
NM_010577
타겟 영역
Exon 3~9
유효 영역 크기
~3.1 kb
유전자 연구 개요
Itga5, also known as Integrin subunit alpha 5, is a member of the integrin adhesion molecule family. Integrins are crucial in cell-matrix adhesion and cell-cell interactions. Itga5 is involved in multiple signaling pathways such as the FAK/PI3K/AKT pathway, which is associated with cell survival, proliferation, and migration [1,2,3,4,6,7,8]. It plays an important role in various biological processes, including tumor angiogenesis, cancer cell progression, and synaptic integrity. Gene knockout (KO) or conditional knockout (CKO) mouse models can be valuable for studying its functions in vivo.
In cancer research, knockdown of Itga5 in tumor cells showed significant effects. In cervical cancer, ITGA5-targeting siRNA decreased the ability of tumor cells to promote endothelial tube formation, indicating its role in angiogenesis [2]. In pancreatic stellate cells, inhibiting ITGA5 using AV3 peptide or siRNA knockdown impaired the proliferation and migration of these cells and also affected the cancer-like characteristics of co-cultured pancreatic cancer cells [4]. In laryngeal squamous cell carcinoma, elevated ITGA5 promoted cancer progression, and inhibition of ITGA5 sensitized cancer cells to cisplatin [3]. In glioma, ITGA5 was associated with drug resistance, and its overexpression enhanced vascular mimicry formation in temozolomide-resistant cells [6]. In non-small cell lung cancer, ITGA5 was involved in IGFBP2-mediated gefitinib resistance [7]. In head and neck squamous cell carcinoma, ITGA5 may be a prognostic marker related to tumor metastasis, immunosuppression, and chemotherapy resistance [8]. In triple-negative breast cancer, circRPPH1 regulated ITGA5 expression as a molecular sponge for miR-326, activating the FAK/PI3K/AKT pathway to promote cancer progression [1].
In conclusion, Itga5 is essential in regulating multiple biological processes. Through model-based research, especially KO/CKO mouse models, its role in various cancer types has been revealed, such as promoting tumor angiogenesis, cancer cell progression, and being associated with drug resistance. Understanding Itga5's functions provides potential therapeutic targets for cancer treatment. In Parkinson's disease, Itga5 is also crucial for maintaining synaptic integrity and motor coordination, highlighting its importance in non-cancerous disease areas as well [5].
References:
1. Zhang, Chuanpeng, Yu, Ziyi, Yang, Susu, Li, Minghui, Zhao, Yi. 2024. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner. In Molecular cancer, 23, 33. doi:10.1186/s12943-024-01944-w. https://pubmed.ncbi.nlm.nih.gov/38355583/
2. Xu, Xiaohan, Shen, Lulu, Li, Wenhan, Yang, Ping, Cai, Jing. 2023. ITGA5 promotes tumor angiogenesis in cervical cancer. In Cancer medicine, 12, 11983-11999. doi:10.1002/cam4.5873. https://pubmed.ncbi.nlm.nih.gov/36999964/
3. Li, Dapeng, Sun, Anjiang, Zhang, Liang, Zha, Xiaojun, Liu, Yehai. 2022. Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2. In Theranostics, 12, 7431-7449. doi:10.7150/thno.76232. https://pubmed.ncbi.nlm.nih.gov/36438491/
4. Wang, Tao, Yang, Jian, Mao, Juanli, Cheng, Chao, Zhang, Lu. 2022. ITGA5 inhibition in pancreatic stellate cells re-educates the in vitro tumor-stromal crosstalk. In Medical oncology (Northwood, London, England), 40, 39. doi:10.1007/s12032-022-01902-w. https://pubmed.ncbi.nlm.nih.gov/36469173/
5. Zhang, Bei, Hu, Yong-Bo, Li, Gen, Li, Hong-Xia, Li, Gang. 2024. Itga5-PTEN signaling regulates striatal synaptic strength and motor coordination in Parkinson's disease. In International journal of biological sciences, 20, 3302-3316. doi:10.7150/ijbs.96116. https://pubmed.ncbi.nlm.nih.gov/38993558/
6. Shi, Ying, Wu, Mengwan, Liu, Yuyang, Chen, Ling, Xu, Chuan. 2021. ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma. In Frontiers in oncology, 11, 769592. doi:10.3389/fonc.2021.769592. https://pubmed.ncbi.nlm.nih.gov/34976814/
7. Lu, Hengxiao, Ai, Jiangshan, Zheng, Yingying, Zhang, Heng, Wang, Shaoqiang. 2024. IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer. In Cell death & disease, 15, 447. doi:10.1038/s41419-024-06843-y. https://pubmed.ncbi.nlm.nih.gov/38918360/
8. Liu, Jianmin, Wang, Yongkuan, Chen, Xi, Chen, Xiaofang, Zhang, Meng. 2024. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma. In Diagnostic pathology, 19, 134. doi:10.1186/s13000-024-01559-1. https://pubmed.ncbi.nlm.nih.gov/39375732/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
